5,782 Shares in Agilent Technologies, Inc. $A Bought by Arrowpoint Investment Partners Singapore Pte. Ltd.

Arrowpoint Investment Partners Singapore Pte. Ltd. purchased a new position in Agilent Technologies, Inc. (NYSE:A) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 5,782 shares of the medical research company’s stock, valued at approximately $742,000.

A number of other hedge funds also recently made changes to their positions in A. Vanguard Group Inc. boosted its position in shares of Agilent Technologies by 1.8% during the second quarter. Vanguard Group Inc. now owns 33,997,845 shares of the medical research company’s stock valued at $4,012,086,000 after buying an additional 589,219 shares during the period. Massachusetts Financial Services Co. MA increased its position in shares of Agilent Technologies by 10.7% during the second quarter. Massachusetts Financial Services Co. MA now owns 13,227,387 shares of the medical research company’s stock worth $1,560,964,000 after acquiring an additional 1,273,994 shares during the period. Geode Capital Management LLC raised its stake in shares of Agilent Technologies by 1.6% during the second quarter. Geode Capital Management LLC now owns 7,319,530 shares of the medical research company’s stock valued at $860,137,000 after acquiring an additional 115,183 shares in the last quarter. Generation Investment Management LLP lifted its position in shares of Agilent Technologies by 10.1% in the 3rd quarter. Generation Investment Management LLP now owns 6,357,953 shares of the medical research company’s stock worth $816,043,000 after purchasing an additional 582,093 shares during the period. Finally, Norges Bank purchased a new position in Agilent Technologies in the second quarter valued at about $395,088,000.

Analysts Set New Price Targets

A has been the topic of several recent analyst reports. HSBC began coverage on Agilent Technologies in a research report on Tuesday, January 20th. They set a “buy” rating and a $180.00 target price on the stock. Barclays lowered their target price on Agilent Technologies from $165.00 to $150.00 and set an “overweight” rating on the stock in a research note on Thursday, February 26th. TD Cowen reduced their price target on Agilent Technologies from $170.00 to $157.00 and set a “buy” rating for the company in a research report on Thursday, February 26th. Evercore raised shares of Agilent Technologies from an “in-line” rating to an “outperform” rating and lifted their target price for the company from $155.00 to $160.00 in a report on Monday, January 5th. Finally, Robert W. Baird boosted their target price on shares of Agilent Technologies from $142.00 to $165.00 and gave the company an “outperform” rating in a research note on Tuesday, November 25th. Two equities research analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $161.20.

Agilent Technologies Stock Down 0.0%

A stock opened at $111.60 on Friday. The company has a market cap of $31.54 billion, a price-to-earnings ratio of 24.64, a price-to-earnings-growth ratio of 2.35 and a beta of 1.31. The company has a fifty day moving average price of $130.34 and a 200 day moving average price of $135.71. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.07 and a quick ratio of 1.59. Agilent Technologies, Inc. has a 12 month low of $96.43 and a 12 month high of $160.27.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, February 25th. The medical research company reported $1.36 EPS for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The business had revenue of $1.80 billion during the quarter, compared to analyst estimates of $1.81 billion. During the same quarter in the prior year, the firm posted $1.31 earnings per share. The company’s revenue for the quarter was up 7.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. Sell-side analysts expect that Agilent Technologies, Inc. will post 5.58 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 22nd. Investors of record on Tuesday, March 31st will be given a $0.255 dividend. This represents a $1.02 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Tuesday, March 31st. Agilent Technologies’s dividend payout ratio (DPR) is 22.52%.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.